Expert Interviews

Stephen Liu, MD, on How Targeted Therapy Results in Significant Efficacy for RET-Altered Tumors
June 22, 2021

At the 2021 ASCO Annual Meeting, Stephen Liu, MD, discussed the important of findings from the ARROW trial of pralsetinib in patients with RET-altered non–small cell lung cancer.

Suresh S. Ramalingam, MD, Discusses Adjuvant Therapy for Early NSCLC at 2021 ASCO
June 21, 2021

During the 2021 ASCO Annual Meeting, Suresh S. Ramalingam, MD, looked forward to how trials regarding adjuvant therapy for early-stage non–small cell lung cancer are poised to change the treatment paradigm in this setting.

Neal D. Shore, MD, on the Importance of Multidisciplinary Care in Advanced Prostate Cancer
June 21, 2021

Neal D. Shore, MD, FACS, discusses the importance of multidisciplinary care for patients with advanced prostate cancer.